FCM
VTYX

Farallon Capital Management’s Ventyx Biosciences VTYX Stock Holding History

Farallon Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,170,000
Closed -$6.91M – 178
2024
Q3 		$6.91M Hold
3,170,000
– – 0.04% 90
2024
Q2 		$7.32M Hold
3,170,000
– – 0.04% 86
2024
Q1 		$17.4M Buy
+3,170,000
New +$14.5M 0.1% 79
2022
Q4 		– Sell
-70,000
Closed -$2.44M – 255
2022
Q3 		$2.44M Sell
70,000
-860,648
-92% -$19.1M 0.02% 205
2022
Q2 		$11.4M Sell
930,648
-183,632
-16% -$2.74M 0.07% 128
2022
Q1 		$15.1M Hold
1,114,280
– – 0.08% 113
2021
Q4 		$22.1M Buy
+1,114,280
New +$21.1M 0.12% 91

Other funds holding VTYX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return